| mRNA |
myriocin |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.9 |
| mRNA |
tacrolimus |
CTRPv2 |
pan-cancer |
AAC |
0.0061 |
0.9 |
| mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0061 |
0.9 |
| mRNA |
SZ4TA2 |
CTRPv2 |
pan-cancer |
AAC |
-0.0094 |
0.9 |
| mRNA |
necrostatin-7 |
CTRPv2 |
pan-cancer |
AAC |
-0.0063 |
0.9 |
| mRNA |
N9-isopropylolomoucine |
CTRPv2 |
pan-cancer |
AAC |
-0.0059 |
0.9 |
| mRNA |
JQ-1:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0053 |
0.9 |
| mRNA |
brivanib |
CTRPv2 |
pan-cancer |
AAC |
-0.0057 |
0.9 |
| mRNA |
BRD-A05715709 |
CTRPv2 |
pan-cancer |
AAC |
-0.009 |
0.9 |
| mRNA |
FSC231 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.9 |